Xinma Bio
Shaoxing
About Xinma Bio
Xinma Bio engages in the development and production of biological products. The company has expertise and capacities in genetic engineering development, cell culture, toxin synthesis, ADC coupling, preparation filling, preclinical research, and clinical research. Xinma Bio aims to continuously improve the level of research and development technology.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Total funding: $59.5M
- Funding stage: Early Stage Venture
- Last round: Series B (Jul 2022)
- Website: novocodex.cn
- Phone: 0575-85211803
Industries & Categories
Biopharma, Biotechnology, Genetics, Health Care, Manufacturing
Canonical: https://fsome.com/organization/xinma-bio-16260 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.